Skip to main content

Advertisement

SpringerLink
Log in

Is laparoscopic gastrectomy safe for western patients with gastric cancer with high body mass index?

  • Letter
  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kappas AM et al (2002) Quality of surgery determinant for the outcome of patient with gastric cancer. Ann Surg Oncol 9(9):828–830

    Article  PubMed  Google Scholar 

  2. Roukos DH (2009) Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer. Ann Surg Oncol 16(4):795–798

    Article  PubMed  Google Scholar 

  3. Liakakos T et al (2008) More controversy than ever: challenges and promises towards personalized treatment of gastric cancer. Ann Surg Oncol 15(4):956–960

    Article  PubMed  Google Scholar 

  4. Roukos DH, Paraschou P, Lorenz M (2000) Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery. Ann Surg Oncol 7(10):719–726

    Article  CAS  PubMed  Google Scholar 

  5. Roukos DH, Kappas AM (2002) Targeting the optimal extent of lymph node dissection for gastric cancer. J Surg Oncol 81:59–62

    Article  PubMed  Google Scholar 

  6. Kappas AM et al (2004) Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11:727–730

    Article  PubMed  Google Scholar 

  7. Liakakos T, Roukos DH (2009) Randomized evidence for laparoscopic gastrectomy short-term quality of life improvement and challenges for improving long-term outcomes. Ann Surg 250(2):349–350

    Article  PubMed  Google Scholar 

  8. Liakakos T, Roukos D (2008) Laparoscopic gastrectomy: advances enable wide clinical application. Surg Endosc 22(6):1553–1555

    Article  CAS  PubMed  Google Scholar 

  9. Roukos DH, Hottenrott C, Lorenz M, Koutsogiorgas-Couchell S (1990) A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach. An analysis of early results and long-term survival. J Cancer Res Clin Oncol 116:307–311

    Article  CAS  PubMed  Google Scholar 

  10. Roukos DH, Hottenrott C, Encke A, Baltogiannis G, Casioumis D (1994) Primary gastric lymphomas: a clinicopathologic study with literature review. Surg Oncol 3(2):115–125

    Article  CAS  PubMed  Google Scholar 

  11. Roukos DH (2004) Early-stage gastric cancer: a highly treatable disease. Ann Surg Oncol 11:127–129

    Article  PubMed  Google Scholar 

  12. Briasoulis E, Fatouros M et al (2007) Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14:2691–2695

    Article  PubMed  Google Scholar 

  13. Roukos DH (2002) Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9:220–221

    Article  PubMed  Google Scholar 

  14. Briasoulis E, Liakakos T, Dova L et al (2006) Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Expert Rev Anticancer Ther 6:931–939

    Article  PubMed  Google Scholar 

  15. Roukos DH (2009) Mea culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networks-based, personalized biomedicine. Expert Rev Mol Diagn 9(3):217–221

    Article  PubMed  Google Scholar 

  16. Strong VE, Devaud N, Allen PJ et al (2009) Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol 16(6):1507–1513

    Article  PubMed  Google Scholar 

  17. Lee HJ, Kim HH, Kim MC et al (2009) The impact of a high body mass index on laparoscopy assisted gastrectomy for gastric cancer. Surg Endosc Apr 3 [Epub ahead of print]

  18. Roukos DH (2009) Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention. Expert Rev Mol Diagn 9(1):1–6

    Article  CAS  PubMed  Google Scholar 

  19. Roukos DH (2009) Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine. Ann Surg Oncol 16(3):772–773

    Article  PubMed  Google Scholar 

  20. Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the “Gordian Knot”? Ann Surg Oncol 16(3):774–775

    Article  PubMed  Google Scholar 

  21. Ziogas D, Baltogiannis G, Fatouros M et al (2008) Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations. Ann Surg 247(4):714–715

    Article  PubMed  Google Scholar 

  22. Roukos DH (2009) Radiation therapy for breast cancer. N Engl J Med 360(13):1362–1363

    Article  CAS  PubMed  Google Scholar 

  23. Roukos DH (2009) Twenty-one-gene assay: challenges and promises in translating personal genomics and whole-genome scans into personalized treatment of breast cancer. J Clin Oncol 27(8):1337–1338

    Article  PubMed  Google Scholar 

  24. Roukos DH (2008) Breast-cancer stromal cells with TP53 mutations. N Engl J Med 358(15):1636

    CAS  PubMed  Google Scholar 

  25. Fatouros M et al (2008) The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol 15(1):21–33

    Article  PubMed  Google Scholar 

  26. Fatouros M et al (2005) Factors increasing local recurrence in breast-conserving surgery. Expert Rev Anticancer Ther 5(4):737–745

    Article  PubMed  Google Scholar 

  27. Roukos DH (2007) Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations. N Engl J Med 357(2):1555–1556

    CAS  PubMed  Google Scholar 

  28. Roukos DH (2009) Genome-wide association studies: how predictable is a person’s cancer risk? Expert Rev Anticancer Ther 9(4):389–392

    Article  PubMed  Google Scholar 

  29. Roukos DH (2009) Personalized cancer diagnostics and therapeutics. Expert Rev Mol Diagn 9(3):227–229

    Article  PubMed  Google Scholar 

  30. Roukos DH (2009) Breast cancer outcomes: the crucial role of the breast surgeon in the era of personal genetics and systems biology. Ann Surg 249(6):1067–1068

    Article  PubMed  Google Scholar 

  31. Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16(7):1771–1782

    Article  PubMed  Google Scholar 

Download references

Disclosure

Profs. D. Kanellos and I. Kanellos have no conflicts of interest or financial ties to disclose.

Author information

Authors and Affiliations

  1. 4th Department of Surgery, Aristotle University of Thessaloniki , Thessaloniki, Greece

    D. Kanellos & I. Kanellos

Authors
  1. D. Kanellos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Kanellos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to I. Kanellos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanellos, D., Kanellos, I. Is laparoscopic gastrectomy safe for western patients with gastric cancer with high body mass index?. Surg Endosc 24, 977–979 (2010). https://doi.org/10.1007/s00464-009-0696-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-009-0696-8

Keywords

Search

Navigation